Newsroom
Sorted by: Latest
-
DNOW Announces Fourth Quarter and Full-Year 2025 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--DNOW Announces Fourth Quarter and Full-Year 2025 Earnings Conference Call...
-
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. The BRAFTOVI regimen demonstrated a statistically sig...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.02.2026 FEUD IE00BF2FL590 363,962.00 EUR 19,740,678.50 54.238 ...
-
Henry Schein One Connects Align Technology’s iTero™ Scanners to Dentrix, Dentrix Ascend, and Dentally, Advancing a More Connected Global Standard of Care
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced a direct data integration between Align Technology’s iTero™ intraoral scanners and its core practice management platforms—Dentrix, Dentrix Ascend, and Dentally—creating a seamless connection between digital scanning, diagnosis, and daily operations for practices worldwide. Developed in collaboration with Align Technology, the integration automatically imports iTero scans into patient records, eliminating manual uploads, dupl...
-
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful achievement of the primary endpoint in the ongoing Phase 3 COMP006 trial, the second of two Phase 3 trials, which is evaluating two fixed doses of COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). The primary endpoint was the difference in change...
-
Herc Holdings Reports Full Year 2025 Results and Announces 2026 Full Year Guidance
BONITA SPRINGS, Fla.--(BUSINESS WIRE)--Herc Holdings Inc. (NYSE: HRI) ("Herc Holdings" or the "Company") today reported financial results for the quarter and full year ended December 31, 2025. “2025 was a pivotal year for Herc Rentals. In June, we completed the largest acquisition in our industry, bringing together two high‑quality equipment rental operators to create significant long‑term strategic and financial value,” said Larry Silber, chief executive officer. “We are extremely pleased with...
-
Anaergia, Eni and CREvolution Unveil Breakthrough Platform to Scale Demand for Biodiesel and SAF
GELA, Italy & BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia (TSX: ANRG; OTCQX: ANRGF), Eni & CREvolution launch breakthrough circular HVO platform at Gela, scaling biodiesel & SAF....
-
Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, 2026. To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company’s website, teleflex.com. An audio replay of the call will be available be...
-
Orion S.A. Reports Full Year 2025 and Fourth Quarter Earnings
HOUSTON--(BUSINESS WIRE)--Orion S.A. (NYSE: OEC), a specialty chemical company, today reported full year 2025 Net sales of $1.8 billion in 2025, a 4% decrease from the prior year, consisting of a 7% decline in price, including the pass-through effect of lower oil prices, offset by a 2% increase in volume and favorable foreign currency translation. Historically high levels of lower-tier tire imports into the Western Hemisphere and persistently soft demand in key industrial end-markets including...
-
Pennsylvania Small Businesses Expand into Global Markets With Assist from Coupang
PITTSBURGH--(BUSINESS WIRE)--Pennsylvania businesses are expanding abroad with Coupang, a U.S.-technology company that helps American companies sell internationally....